Disease: Alzheimer Disease*
Disease: Alzheimer disease (AD)
Organism: postmortem human brain tissue
Specimen: microdissected tissues
Specimen: Consecutive sections (20 μm)
Specimen: paraffin-embedded hippocampal sections (5 μm)
CellType: MOPP (molecular layer perforant path-associated) cells
OrganismPart: outer two-thirds of the molecular layer of the dentate gyrus
Instrument: UltiMate™ 3000 RSLCnano System
Instrument: hybrid Q-Exactive-HF mass spectrometer
FractionationMethod: high resolution isoelectric focusing (HiRIEF) protocol
NumberOfFractions: 72 fractions
ReductionReagent: DTT
ConcentrationOfCompound: 1 mm DTT
AlkylationReagent: chloroacetamide
ConcentrationOfCompound: 4 mm chloroacetamide
Compound: SDS
ConcentrationOfCompound: 4% SDS
Compound: Hepes
ConcentrationOfCompound: 25 mm Hepes pH 7.6
CleavageAgent: Lys-C
CleavageAgent: trypsin
Time: 16 h
Temperature: 95 °C
Time: 5 min
Time: 1 min
FlowRateChromatogram: 250 nl/min
PrecursorMassTolerance: 10 ppm
FragmentMassTolerance: 0.02 Da
FragmentationMethod: higher energy collision dissociation
CollisionEnergy: 30–40% normalized collision energy
NumberOfMissedCleavages: maximum 2 missed cleavages
Modification: TMT10plex on lysine residues and peptide N termini
Modification: carbamidomethylation on cysteine residues
Modification: oxidation on methionine residues
NumberOfTechnicalReplicates: No technical replicates were performed
NumberOfSamples: ten samples
BiologicalReplicate: five subjects with AD
BiologicalReplicate: five controls
Genotype: ApoE4 carriers
SampleTreatment: fixed in 75% ethanol
Staining: toluidine blue
Temperature: 110 °C
Time: 30 min
Staining: DAB
SourceName: Netherlands Brain Bank
SourceName: Carroll A. Campbell Jr. Neuropathology Laboratory (CCNL) Brain Bank
FactorValue: AD Braak stage 4
FactorValue: amyloid deposits stage C
FactorValue: AD Braak stage 0–2
FactorValue: amyloid deposits stage 0-B
AssayName: quantitative MS
AssayName: LC-MS/MS
AssayName: immunohistochemistry
SupplementaryFile: PXD014557